Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_4
2
67%
Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 42 (66.7%)

Trials by Status

completed133%
active_not_recruiting133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
completedphase_4

Estradiol and Progesterone Levels Following Frozen Embryo Transfer

NCT04997525
active_not_recruitingphase_4

Drug-Drug Interaction Study in Trans Women Living With HIV

NCT05663892
terminatedearly_phase_1

Coagulation and Fibrinolysis of Estradiol in Transwomen

NCT05387577

Clinical Trials (3)

Showing 3 of 3 trials
NCT04997525Phase 4

Estradiol and Progesterone Levels Following Frozen Embryo Transfer

Completed
NCT05663892Phase 4

Drug-Drug Interaction Study in Trans Women Living With HIV

Active Not Recruiting
NCT05387577Early Phase 1

Coagulation and Fibrinolysis of Estradiol in Transwomen

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3